Orgonex Technologies develops a patented semi-automated spinning bioreactor that enhances organoid culture by improving media mixing and oxygenation. This technology reduces the costs and complexity of organoid research while increasing yield by an average of five times.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of culturing organoids are often tedious, expensive, and lack standardization, hindering the pace and increasing the costs of organoid research. These manual processes limit scalability and can introduce variability, impacting the reliability of downstream applications in toxicology, personalized medicine, and regenerative medicine.
Solution
Orgonex Technologies offers the RPMotion bioreactor, a semi-automated spinning bioreactor designed to enhance organoid culture through improved media mixing and oxygenation. The system automates the organoid culturing procedure, standardizing the process and reducing the need for manual intervention. The RPMotion bioreactor connects to standard culture stoves and control units, allowing for real-time monitoring and control of organoid cultures. The gentle rotation of the bioreactor, facilitated by patented stirring rods, ensures optimal mixing of media components and improved oxygenation, creating an ideal environment for organoid growth and expansion.
Target Audience
The primary target audience includes scientists and companies in the fields of toxicology, personalized medicine, and regenerative medicine who are looking to reduce the costs, increase the pace, and standardize their organoid research.
Features
- Semi-automated spinning bioreactor for enhanced organoid culture
- Patented stirring rods for optimal mixing of cells and media components
- Improved oxygenation of the culture environment
- Compatibility with standard culture stoves and control units
- Real-time monitoring and control of organoid cultures
- Increased organoid yield by an average of five-fold